Boehringer hits Teva with counterpunch in inhaler patent battle

Christian Dimitriadis 2019-03-04 9:53 pm By Cat Fredenburgh | Melbourne

Please login to bookmark

German pharmaceutical company Boehringer has struck back at a patent lawsuit brought by Teva, filing a cross-claim alleging Teva is threatening to infringe three of its patents related to its blockbuster inhaler Spiriva with the planned launch of a competing inhaler in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au